Stock Analysis

3 Stocks That May Be Trading Below Their Estimated Intrinsic Value

SWX:GALD
Source: Shutterstock

In a week marked by volatility, global markets have been influenced by a mix of corporate earnings reports and geopolitical developments, with U.S. stocks experiencing fluctuations amid AI competition fears and tariff concerns. As investors navigate these complex market conditions, identifying stocks that may be trading below their estimated intrinsic value can offer potential opportunities for those looking to capitalize on discrepancies between market prices and underlying worth.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Wistron (TWSE:3231)NT$99.00NT$197.6249.9%
Alltop Technology (TPEX:3526)NT$265.00NT$528.7849.9%
Decisive Dividend (TSXV:DE)CA$5.90CA$11.7950%
Northwest Bancshares (NasdaqGS:NWBI)US$13.17US$26.3149.9%
Emporiki Eisagogiki Aftokiniton Ditrohon kai Mihanon Thalassis Societe Anonyme (ATSE:MOTO)€2.72€5.4349.9%
Telefonaktiebolaget LM Ericsson (OM:ERIC B)SEK83.22SEK165.9049.8%
Spin Master (TSX:TOY)CA$30.23CA$60.1749.8%
Coastal Financial (NasdaqGS:CCB)US$86.74US$172.6849.8%
Equifax (NYSE:EFX)US$266.77US$531.7849.8%
Facephi Biometria (BME:FACE)€2.23€4.4549.8%

Click here to see the full list of 930 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Kuaishou Technology (SEHK:1024)

Overview: Kuaishou Technology is an investment holding company that offers live streaming, online marketing, and other services in the People’s Republic of China, with a market cap of approximately HK$188.60 billion.

Operations: The company's revenue segments are comprised of Domestic operations generating CN¥119.83 billion and Overseas operations contributing CN¥4.25 billion.

Estimated Discount To Fair Value: 48.9%

Kuaishou Technology is trading at a significant discount to its estimated fair value, with shares priced 48.9% below this benchmark. The company's recent earnings report shows robust growth, with net income rising substantially year-over-year. Despite revenue growth projections being moderate at 8.7% annually, the company is expected to achieve higher profit growth compared to the Hong Kong market average. Recent product innovations and strategic buybacks further enhance its investment appeal based on cash flows.

SEHK:1024 Discounted Cash Flow as at Feb 2025
SEHK:1024 Discounted Cash Flow as at Feb 2025

Galderma Group (SWX:GALD)

Overview: Galderma Group AG is a global dermatology company with a market capitalization of CHF26.90 billion.

Operations: The company's revenue segment includes Dermatology, generating $4.32 billion.

Estimated Discount To Fair Value: 48.9%

Galderma Group is trading at a significant discount, priced 48.9% below its estimated fair value of CHF227.38. Despite revenue growth being moderate at 11.1% annually, earnings are projected to grow by 36.57% per year, with profitability expected within three years—above the market average growth rate. Recent clinical trials and product innovations in their aesthetics portfolio highlight potential for sustained cash flow improvements, reinforcing its attractiveness as an undervalued stock based on cash flows.

SWX:GALD Discounted Cash Flow as at Feb 2025
SWX:GALD Discounted Cash Flow as at Feb 2025

CCC (WSE:CCC)

Overview: CCC S.A. is a footwear company operating in Poland, Central and Eastern Europe, and Western Europe with a market cap of PLN11.76 billion.

Operations: The company's revenue segments include Dee Zee with PLN85.10 million, Eobuwie generating PLN3.01 billion, CCC Omnichannel contributing PLN4.31 billion, Modivo Omnichannel at PLN1.05 billion, and Halfprice Omnichannel with PLN1.68 billion.

Estimated Discount To Fair Value: 23.1%

CCC is trading at PLN176.3, significantly below its estimated fair value of PLN229.34, highlighting its undervaluation based on cash flows. The company recently became profitable, with third-quarter net income surging to PLN155.4 million from PLN5.1 million a year ago. Despite interest payment challenges, earnings are forecast to grow at 26.9% annually over three years—outpacing the Polish market—and revenue growth is expected at 11.7% per year, reflecting strong future prospects.

WSE:CCC Discounted Cash Flow as at Feb 2025
WSE:CCC Discounted Cash Flow as at Feb 2025

Next Steps

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SWX:GALD

Galderma Group

Operates as a dermatology company worldwide.

Reasonable growth potential with adequate balance sheet.

Community Narratives

Leading the Game with Growth, Innovation, and Exceptional Returns
Fair Value SEK 300.00|49.2% undervalued
Investingwilly
Investingwilly
Community Contributor
Why ASML Dominates the Chip Market
Fair Value €864.91|17.633% undervalued
yiannisz
yiannisz
Community Contributor
Global Payments will reach new heights with a 34% upside potential
Fair Value US$142.00|22.5% undervalued
Maxell
Maxell
Community Contributor